Cengild Medical Bhd is probably on the worst performing healthcare listed on Bursa Malaysia.
The counter lost about 35% in value to close at 30 sen on May 16.
Shareholders must be agonising over the drop in the share price since its listing in April 2022 at an IPO price of 33 sen.
Cengild only managed to touch a 52-week high of 46 sen in August last year.
However, things are looking up for the healthcare provider could continue its technical rebound after breaking out from a downtrend channel in Apr 2024.
The stock could swing towards resistance thresholds of 34.5 sen and 37.5 sen.
Investors are mostly unhappy with the specialist in gastrointestinal and liver diseases for its move to change of business model from asset light to heavy.
To set up a hospital is costly twith gestation period of between 3 to 5 years upon completion.
The property is part of a proposed construction of a 17-storey medical centre building in Kuala Lumpur to be constructed with a floor area of 187,507 sq ft based on plot ratio.
Cengild is proposing to acquire building space with a combined strata floor area of 100,442 sq ft together with at least 182 car park bays.
On the other hand, some investors believe there is no reason for the overreaction in the shares sell-off following the announcement on the purchase of the building.
This is because the pivot from renting a building to totally owning one seems rational, given there is a huge business risk if the landlord takes back the property.
Another positive on the company is its strong balance sheet.
It has no debt and sits on a cash pile of RM102 million (or 12.2 sen per share as of end-Dec 2023) or 40% of its existing market cap.
This should support any of its acquisition plans.
Earnings-wise, Cengild is not exactly in a rosy position.
Its net profit fell 30% year-on-year to RM2.9 million in 2QFY24
On a 1HFY basis, its bottomline declined 16% year-on-year to RM6.5 million.
Based on its book value per share of 13 sen as of end-Dec 2023, the stock is currently
trading at a price to book value multiple of 2.3x.
Investors may be losing patience with the counter given its unexciting share price movement but it may soon change as its business bears fruit in the near term.
Chart | Stock Name | Last | Change | Volume |
---|
Created by zaclim | Aug 29, 2024
AirAsia X Bhd is still not out of the woods but is seeing a rebound after its share price rose to a high of RM1.35 recently. Can it continue to fly higher?
Created by zaclim | Aug 28, 2024
Cuscapi Bhd has gained 50% in terms of value year-to-date and signs indicate that the good run still has legs.
Created by zaclim | Aug 27, 2024
After a turnaround in its financials, Pesona Metro Holdings Bhd has been attracting investors’ interest especially after bagging 4 contracts in a year. Will its good run in share price be sustainable?
Created by zaclim | Aug 26, 2024
Able Global Bhd has been surging in recent weeks although still shy of its 52-week high seen in June. Will the counter be able to reach its high?
Created by zaclim | Aug 26, 2024
Johor Plantations Group Bhd may not have performed as well as other listings this year but signs indicate the counter might trend higher
Created by zaclim | Aug 22, 2024
AEON Co. (M) Bhd is experiencing significant growth, with its stock hitting a 52-week high of RM1.54 on August 21, a 30% surge year-to-date. Can it continue to draw investors’ interest?
Created by zaclim | Aug 21, 2024
Capital A Bhd may be racing against time to get itself out of the PN17 status but its share price has been moving upwards. Can it maintain its positive run?
Created by zaclim | Aug 20, 2024
PBA has been making a big splash following the revisions on water tariff. This goes to enhance it bottomline and provide a catalyst for investors looking for exposure in this segment.
Created by zaclim | Aug 19, 2024
Vestland Bhd has been building a strong momentum after it dipped to its low of 30 sen in January. Can it continue to make a good run?
Created by zaclim | Aug 16, 2024
Investors should be happy that pole maker Mestron Holdings Bhds seeing a strong rise in its share price in the past 5 days, igniting hopes of sustained upward momentum